These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24568609

  • 21. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N, Tran TH, Poudel BK, Cho HJ, Choi YK, Chi SC, Choi HG, Yong CS, Kim JO.
    Int J Pharm; 2013 Jan 30; 441(1-2):424-32. PubMed ID: 23174408
    [Abstract] [Full Text] [Related]

  • 22. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
    Hussain T, Saeed T, Mumtaz AM, Javaid Z, Abbas K, Awais A, Idrees HA.
    Acta Pol Pharm; 2013 Jan 30; 70(4):749-57. PubMed ID: 23923399
    [Abstract] [Full Text] [Related]

  • 23. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP, Gaikwad NJ.
    Acta Pharm; 2009 Mar 30; 59(1):57-65. PubMed ID: 19304558
    [Abstract] [Full Text] [Related]

  • 24. Dissolution enhancement of gliclazide using ultrasound waves and stabilizers in liquid anti-solvent precipitation.
    Al-Nimry SS, Qandil AM, Salem MS.
    Pharmazie; 2014 Dec 30; 69(12):874-80. PubMed ID: 25951659
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo characterization of fast dissolving tablets containing gliquidone-pluronic solid dispersion.
    Mohamed MS, Abdelhafez WA, Zayed G, Samy AM.
    Drug Dev Ind Pharm; 2019 Dec 30; 45(12):1973-1981. PubMed ID: 31692385
    [Abstract] [Full Text] [Related]

  • 26. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS, Biradar SV, Aher S, Paradkar AR.
    J Pharm Pharmacol; 2009 Jun 30; 61(6):743-51. PubMed ID: 19505364
    [Abstract] [Full Text] [Related]

  • 27. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
    Jung HJ, Ahn HI, Park JY, Ho MJ, Lee DR, Cho HR, Park JS, Choi YS, Kang MJ.
    Int J Biol Macromol; 2016 Feb 30; 83():282-7. PubMed ID: 26642839
    [Abstract] [Full Text] [Related]

  • 28. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
    Daraghmeh N, Chowdhry BZ, Leharne SA, Al Omari MM, Badwan AA.
    Mar Drugs; 2015 Mar 30; 13(4):1739-64. PubMed ID: 25830680
    [Abstract] [Full Text] [Related]

  • 29. Moisture sorption behavior of selected bulking agents used in lyophilized products.
    Fakes MG, Dali MV, Haby TA, Morris KR, Varia SA, Serajuddin AT.
    PDA J Pharm Sci Technol; 2000 Mar 30; 54(2):144-9. PubMed ID: 10822985
    [Abstract] [Full Text] [Related]

  • 30. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives.
    Chawla G, Bansal AK.
    Acta Pharm; 2008 Sep 30; 58(3):257-74. PubMed ID: 19103563
    [Abstract] [Full Text] [Related]

  • 31. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.
    Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG.
    AAPS PharmSciTech; 2008 Sep 30; 9(2):563-70. PubMed ID: 18459056
    [Abstract] [Full Text] [Related]

  • 32. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
    Barakat NS, Almurshedi AS.
    J Pharm Pharmacol; 2011 Feb 30; 63(2):169-78. PubMed ID: 21235580
    [Abstract] [Full Text] [Related]

  • 33. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS, Shimpi SL, Paradkar AR.
    Acta Pharm; 2007 Sep 30; 57(3):287-300. PubMed ID: 17878109
    [Abstract] [Full Text] [Related]

  • 34. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
    Ha ES, Choo GH, Baek IH, Kim MS.
    Molecules; 2014 Dec 04; 19(12):20325-39. PubMed ID: 25486246
    [Abstract] [Full Text] [Related]

  • 35. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
    Al-Hussein A, Gieseler H.
    J Pharm Sci; 2012 Jul 04; 101(7):2534-44. PubMed ID: 22535541
    [Abstract] [Full Text] [Related]

  • 36. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS, Al-Gohary OM, Al-Faadhel MM.
    Int J Pharm; 2007 Aug 16; 341(1-2):230-7. PubMed ID: 17507189
    [Abstract] [Full Text] [Related]

  • 37. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J, Bao J, Shi X, Sheng X, Su W.
    J Microencapsul; 2018 Aug 16; 35(5):454-466. PubMed ID: 30229692
    [Abstract] [Full Text] [Related]

  • 38. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.
    Hong SS, Lee SH, Lee YJ, Chung SJ, Lee MH, Shim CK.
    J Control Release; 1998 Feb 12; 51(2-3):185-92. PubMed ID: 9685916
    [Abstract] [Full Text] [Related]

  • 39. Mannitol as an Excipient for Lyophilized Injectable Formulations.
    Thakral S, Sonje J, Munjal B, Bhatnagar B, Suryanarayanan R.
    J Pharm Sci; 2023 Jan 12; 112(1):19-35. PubMed ID: 36030846
    [Abstract] [Full Text] [Related]

  • 40. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ, Koolen SL, Huitema AD, Schellens JH, Beijnen JH, Nuijen B.
    Int J Pharm; 2011 Nov 28; 420(2):244-50. PubMed ID: 21907780
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.